NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
12/31/2025
Back to search
Official data from USPTO
NOVALIQ
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
NOVALIQ
ST13
US500000087943588Class
1, 5, 41, 42
Filing
87943588
Registration
5754982
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
29
Latest update
01/20/2026
Trademark type
Word
Nice classes
1, 5, 41, 42
Filing date
05/31/2018
Registration date
05/21/2019
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
12/31/2025
Last transaction
01/20/2026
Responsible office
United States Patent and Trademark Office
Status code
705
Official register
Principal Register
Filing basis
Intent to use, Foreign priority
Drawing code
4
Owner type
99
Owner location
Heidelberg, DE
Examiner
MARTIN,JENNIFER MCGARRY
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Novaliq GmbH
Representatives
Pina M. Campagna Carter, Deluca, & Farrell, LLP
Technical classification
Nice Classes
Class 1Class 5Class 41Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
(based on 44(e)) Chemical and biochemical preparations used in industrysemifluorinated alkanes as bases for manufacturing medical aidsfor manufacturing pharmaceutical or medical preparations; chemical preparations used in industrychemical additives for use in the manufacture of pharmaceuticals
Class 5
(based on 44(e)) Biologicalchemical and biochemical preparations for pharmaceutical or medical purposesophthalmologic and dermatologic preparations; biologicalchemical and biochemical diagnostic preparations for medical use; pharmaceutical preparationsexclusive of medicaments and medicinesfor treating skin diseases and disorders; pharmaceutical preparationsexclusive of medicaments and medicinesfor treating eye diseases and disorders
Class 41
(based on 44(e) with claim of priority under 44(d)) Publishing and issuing scientific papers in relation to medical technology; publishing of electronic publications
Class 42
(based on 44(e) with claim of priority under 44(d)) Pharmaceutical product evaluationpharmaceutical research servicespharmaceutical product developmentconducting early evaluations in the field of new pharmaceuticals
Publications
History of USPTO decisions and trademark events.
29 publications found
C15P
REGISTERED - PARTIAL SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
12/31/2025
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
12/31/2025
E815
TEAS SECTION 8 & 15 RECEIVED
09/26/2025
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
05/21/2024
COC.
CORRECTION UNDER SECTION 7 - PROCESSED
07/16/2019
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
07/11/2019
ES7R
TEAS SECTION 7 REQUEST RECEIVED
06/18/2019
R.PR
REGISTERED-PRINCIPAL REGISTER
05/21/2019
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
03/05/2019
PUBO
PUBLISHED FOR OPPOSITION
03/05/2019
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
02/13/2019
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
01/28/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
12/31/2018
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
12/31/2018
ALIE
ASSIGNED TO LIE
12/31/2018
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
12/22/2018
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
12/22/2018
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
12/19/2018
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
12/19/2018
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
08/09/2018
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
06/27/2018
GNRT
NON-FINAL ACTION E-MAILED
06/27/2018
CNRT
NON-FINAL ACTION WRITTEN
06/27/2018
DOCK
ASSIGNED TO EXAMINER
06/23/2018
TAEA
TEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED
06/07/2018
PARI
TEAS VOLUNTARY AMENDMENT RECEIVED
06/07/2018
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
06/07/2018
NWAP
NEW APPLICATION ENTERED
06/04/2018
Continuous trademark protection
Get notified about every new filing that threatens NOVALIQ or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.